Entity
coIMMUNE, Inc.
Created in 2023
To investigate (B)
Some signals may appear as inconsistent with a regular activitySocial networks
31 784Activities
Technologies
Entity types
Location
4233 Technology Dr, Durham, NC 27704, USA
Durham
United States of America
Employees
Scale: 11-50
Estimated: 8
Engaged catalyst
5
0 0Added in Motherbase
2 years ago
Description
Value proposition
coIMMUNE is a privately held, clinical stage immune-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a novel CAR therapy that promises enhanced efficacy with greatly reduced toxicity.
Home - Benecyte, Inc.
Heterogeneous antigen expression and loss variants- in many cases only a minority of cells express the target antigen Antibody-dependent rejection of infused…
https://www.benecyte.com/ - Website is disabled or domain is for sale
Catalyst interactions
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
 Marriott International Hospitality | Marriott International Hospitality | Other 12 Oct 2022 | | |
 Maddy Keynote 2023 Trade show, IT Services and IT Consulting | Maddy Keynote 2023 Trade show, IT Services and IT Consulting | Other 24 Jan 2020 | | |
 Agence Française de Développement International development, Banking | Agence Française de Développement International development, Banking | Other 20 Sep 2019 | | |
 UN Africa Renewal International development, International Affairs | UN Africa Renewal International development, International Affairs | Other 10 Nov 2022 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 18 Dec 2019 | | |
Social network dynamics
Similar entities
BETA
Loading...
Last news Show all articles
Loading...